Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;69(9):835-840.
doi: 10.1097/MAT.0000000000001984. Epub 2023 Aug 29.

Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?

Affiliations

Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?

Connor L Bracy et al. ASAIO J. .

Abstract

Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported. We describe a cohort of patients supported by left ventricular assist devices (LVADs) presenting to the emergency department (ED) at a high-volume LVAD center while in awake ventricular fibrillation (VF)/ventricular tachycardia (VT). Among 175 patients reviewed, a total of 19 LVAD patients presented to the ED in awake VF/VT between December 2015 and July 2021. On ED presentation, patients maintained a median mean arterial blood pressure (MAP) of 70 mm Hg with a mean LVAD flow of 3.77 L/minute. ED management included cardioversion in the majority of cases: 58% were defibrillated once, 21% were defibrillated multiple times, 68% received amiodarone, and 21% received lidocaine. Inpatient management included defibrillation, ablation, and antiarrhythmic initiation in 37%, 11%, and 84% of cases, respectively. In total, five patients (26%) died with one death attributed to recurrent VT. Our findings support the short-term tolerability of sustained ventricular arrhythmias in LVAD patients, as evidenced by the maintained MAPs and mental status. Clinical teams, however, should be aware of the potential harbinger for in-hospital mortality heralded by an awake VF/VT presentation.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

References

    1. Tsao CW, Aday AW, Almarzooq ZI, et al.: Heart Disease and Stroke Statistics-2022 update: A report from the American Heart Association. Circulation. 145: e153–e639, 2022.
    1. Sanaiha Y, Downey P, Lyons R, Nsair A, Shemin RJ, Benharash P: Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States. J Thorac Cardiovasc Surg. 161: 2083–2091.e4, 2021.
    1. Trachtenberg BH, Estep JD: Roads, maps, and destinations: The journey of left ventricular assist device implantation in ambulatory patients with advanced heart failure. Curr Cardiol Rep. 18: 132, 2016.
    1. Kormos RL, Cowger J, Pagani FD, et al.: The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 38: 114–126, 2019.
    1. Gopinathannair R, Cornwell WK, Dukes JW, et al.: Device therapy and arrhythmia management in left ventricular assist device recipients: A scientific statement from the American Heart Association. Circulation. 139: e967–e989, 2019.

LinkOut - more resources